TANG KEVIN bought AUPH

May 29, 2026 · Form 4 insider transaction

TANG KEVIN bought 2,299 shares of Aurinia Pharmaceuticals Inc. at $15.35 per share, a transaction worth $35.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,299
Price
$15.35
Total value
$35.3K
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateMay 29, 2026
Filing dateJune 2, 2026
Shares owned after12,231,799
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $15.33 to $15.38. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 6.; Tang Capital Partners, LP ("TCP") beneficially owns 7,205,442 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 5,239,039 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 324,814 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 274,811 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV (collectively, the "Funds").

View the original Form 4 on SEC EDGAR